Philips Faces Stock Slump Over Sleep Apnea Machine Safety

Philips, a Dutch electronics and health giant, faces a significant stock drop after the FDA issues a safety warning about its sleep apnea machine, the DreamStation 2. The warning stems from 270 medical device reports related to thermal issues, prompting discussions with the FDA. Despite the safety concerns, Philips emphasizes that the devices can still be used if safety instructions are followed. This issue is part of a series of problems affecting Philips' CPAP machines, including a previous recall due to concerns about a foam component.